Danaher Aktie
| 214,13USD | -1,26USD | -0,58% | 
WKN: 866197 / ISIN: US2358511028
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 69 000 | 80 000 | 81 000 | 63 000 | 63 000 | 
| Umsatz pro Mitarbeiter in Mio. EUR | 0,32 | 0,37 | 0,39 | 0,38 | 0,38 | 
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 13 802 | 11 648 | 15 883 | 13 937 | 9 497 | 
| Summe Anlagevermögen | 62 359 | 71 536 | 68 467 | 70 551 | 68 045 | 
| Summe Aktiva | 76 161 | 83 184 | 84 350 | 84 488 | 77 542 | 
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 36 384 | 38 007 | 34 260 | 30 998 | 27 992 | 
| Summe Eigenkapital | 39 777 | 45 177 | 50 090 | 53 490 | 49 550 | 
| Summe Passiva | 76 161 | 83 184 | 84 350 | 84 488 | 77 542 | 
Adresse
| 2200 Pennsylvania Avenue North West, 20037-1701 Washington | |
| Telefon | +1 (202) 828-0850 | 
| Internet | http://www.danaher.com | 
Management
| 
						A. Shane Sanders
						 Independent Director  | 
				
| 
						Alan G. Spoon
						 Independent Director  | 
				
| 
						Alex de Winter
						 Vice President-New Ventures  | 
				
| 
						Charles W. Lamanna
						 Independent Director  | 
				
| 
						Christopher M. Bouda
						 Chief Accounting Officer & Vice President  | 
				
| 
						Daniel A. Raskas
						 Senior Vice President-Corporate Development  | 
				
| 
						Elias A. Zerhouni
						 Independent Director  | 
				
| 
						Feroz Dewan
						 Independent Director  | 
				
| 
						Georgeann F. Couchara
						 Senior Vice President-Human Resources  | 
				
| 
						Greg Milosevich
						 Executive Vice President-Life Sciences business  | 
				
| 
						Jai Shankar Krishnan
						 Vice President-High Growth Markets  | 
				
| 
						James F. O'Reilly
						 Secretary, Chief Sustainability Officer & SVP  | 
				
| 
						Jessica L. Mega
						 Independent Director  | 
				
| 
						John Bedford
						 Vice President-Investor Relations  | 
				
| 
						John T. Schwieters
						 Independent Director  | 
				
| 
						Jonathan B. Leiken
						 Senior Vice President & General Counsel  | 
				
| 
						Jose-Carlos Gutiérrez-Ramos
						 Chief Science Officer & Senior Vice President  | 
				
| 
						Julie Sawyer Montgomery
						 Executive Vice President-Diagnostics  | 
				
| 
						Linda Hefner Filler
						 Lead Independent Director  | 
				
| 
						Martin Stumpe
						 Chief Technology & AI Officer  | 
				
| 
						Matthew R. McGrew
						 Chief Financial Officer & Executive Vice President  | 
				
| 
						Mitchell P. Rales
						 Director  | 
				
| 
						Rainer M. Blair
						 President, Chief Executive Officer & Director  | 
				
| 
						Raymond C. Stevens
						 Independent Director  | 
				
| 
						Sadik Kassim
						 Chief Technology Officer  | 
				
| 
						Steven Dee
						 Chief Technology Officer  | 
				
| 
						Steven M. Rales
						 Chairman  | 
				
| 
						Teri L. List-Stoll
						 Independent Director  | 
				
| 
						Travis Taylor
						 Manager-Investor Relations  |